Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.

Head & neck - 1 Apr 2016

Takahashi Yoko, Lee Junegoo, Pickering Curtis, Bell Diana, Jiffar Tilahun W, Myers Jeffrey N, Hanna Ehab Y, Kupferman Michael E

Abstract excerpt

BACKGROUND: Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive cancer. Despite multimodal therapy, the prognosis in SNUC remains poor, and new therapies are needed. Thus, the purpose of this study was to explore potential therapeutic targets in SNUC. METHODS: Using the human-derived SNUC MDA8788-6 cell line, we performed whole genome single nucleotide polymorphism (SNP) analysis to identify copy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lapatinib

Share to Mice, Nude

Share to Quinazolines

Share to Receptor, ErbB-2

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 26752332
DOI: 10.1002/hed.24350
PMCID: PMC6453572

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.PMID 26752332Read ↗

Molecular profiling of sinonasal undifferentiated carcinoma.Semantic proximity Read ↗

Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma.Semantic proximity Read ↗

Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion geneSemantic proximity Read ↗

Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.Semantic proximity Read ↗

Loss of SMARCB1 Expression Confers Poor Prognosis to Sinonasal Undifferentiated CarcinomaSemantic proximity Read ↗

Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and OpportunitiesSemantic proximity Read ↗

Genetic Analysis of Sinonasal Undifferentiated Carcinoma Discovers Recurrent SWI/SNF Alterations and a novel PGAP3-SRPK1 Fusion GeneSemantic proximity Read ↗

Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again—A Historical PerspectiveSemantic proximity Read ↗

Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.Semantic proximity Read ↗

Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu expression.Semantic proximity Read ↗

Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.Semantic proximity Read ↗

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.